Lucie Biard Selected Research

Lucie Biard Research Topics

Disease

7	Neoplasms (Cancer) 06/2021 - 01/2017
4	Infections 01/2022 - 12/2017
3	Vasculitis (Vasculitides) 01/2022 - 01/2020
3	Uveitis 01/2022 - 01/2016
2	Macular Edema 01/2022 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 11/2019
2	Hypertension (High Blood Pressure) 01/2020 - 01/2019
2	Cryoglobulinemia 01/2020 - 01/2020
2	Sarcoidosis (Schaumann Disease) 12/2017 - 07/2015
1	Takayasu Arteritis (Arteritis, Takayasu's) 11/2022
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Pancreatitis 01/2022
1	Myocardial Infarction 01/2022
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022
1	Stroke (Strokes) 01/2022
1	Low Vision (Subnormal Vision) 01/2022
1	Retinal Vasculitis 01/2022
1	Inflammation (Inflammations) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021
1	Hematologic Diseases (Blood Diseases) 06/2021
1	Shock 06/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2021
1	Bacteremia 01/2021
1	COVID-19 01/2021
1	Disease Progression 01/2021
1	Atrioventricular Block 01/2020
1	Lymphoma (Lymphomas) 11/2019
1	Burns 02/2019
1	Cross Infection (Nosocomial Infection) 02/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Sepsis (Septicemia) 11/2018
1	Pelvic Neoplasms 11/2018
1	Breast Neoplasms (Breast Cancer) 03/2018
1	Colitis 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Peritonitis 01/2017
1	Adenocarcinoma 01/2017
1	Neutropenic Enterocolitis 01/2017
1	Neutropenia 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Triple Negative Breast Neoplasms 04/2016
1	Pathologic Complete Response 04/2016
1	Melanoma (Melanoma, Malignant) 01/2015

Drug/Important Bio-Agent (IBA)

3	Infliximab (Remicade)FDA Link 01/2022 - 07/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
2	tocilizumab (atlizumab)FDA Link 11/2022 - 01/2022
2	InterferonsIBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	Adalimumab (Humira)FDA Link 01/2022 - 01/2016
2	CryoglobulinsIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2017
1	SteroidsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	pembrolizumabIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	mogamulizumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Oxygen (Dioxygen)IBA 06/2021
1	AnticoagulantsIBA 04/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	CytokinesIBA 01/2021
1	GadoliniumIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	AntibodiesIBA 11/2019
1	Brentuximab VedotinIBA 11/2019
1	Pharmaceutical PreparationsIBA 02/2019
1	CreatinineIBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Phenobarbital (Luminal)FDA Link 03/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2017
1	liquid crystal polymerIBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	IpilimumabIBA 01/2015

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Therapeutics 11/2020 - 01/2016
3	Immunotherapy 11/2020 - 01/2017
2	Artificial Respiration (Mechanical Ventilation) 01/2019 - 01/2017
2	Neoadjuvant Therapy 03/2018 - 04/2016
1	Organ Transplantation 06/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Stem Cell Transplantation 11/2019
1	Catheters 02/2019
1	Length of Stay 02/2019
1	Hematopoietic Stem Cell Transplantation 01/2017